A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease

Patients with type 2 diabetes are at increased cardiovascular risk. Until recently, reductions in HbA(1c) and the use of specific glucose-lowering agents have not had a clear, reproducible benefit in reducing the incidence of cardiovascular disease. However, over the past 5 years, members of two cat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Tariq, Riello, Ralph J, Inzucchi, Silvio E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Pharmacotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054345/
https://www.ncbi.nlm.nih.gov/pubmed/33897837
http://dx.doi.org/10.15420/ecr.2020.01.R1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054345/
https://www.ncbi.nlm.nih.gov/pubmed/33897837
http://dx.doi.org/10.15420/ecr.2020.01.R1

Ejemplares similares